KROS (Keros Therapeutics) FFO


KROS Keros Therapeutics Inc KROS
30 GF Score
Price $10.85
! 3 Warning Signs
View Full Analysis

What is Keros Therapeutics FFO?

FFO (Funds from operations) only applies to REITs.

KROS
30GF Score
Keros Therapeutics Inc KROS
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Keros Therapeutics Business Description

Address 1050 Waltham Street, Suite 302, Lexington, MA, USA, 02421
Keros Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from hematological, pulmonary, and cardiovascular disorders with high unmet medical needs. The company's protein therapeutic product candidate, KER-050, is being developed for the treatment of low blood cells counts, or cytopenias, including anemia and thrombocytopenia, in patients with myelodysplastic syndromes, or MDS, and in patients with myelofibrosis.
30GF Score

Get the complete analysis for KROS

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$10.85
Price